Recombinant Human Osteoprotegerin/OPG/TNFRSF11B (C-His)

Recombinant Human Osteoprotegerin/OPG/TNFRSF11B (C-His)

SKU: BP073-50ug
Recombinant Human Osteoprotegerin is produced by Human 293 Cells. The target gene encoding E22-L401 is expressed with a 8His tag at the C terminus.
  • Accession Number

  • Expression

    Human 293 Cells
  • Background

    Osteoprotegerin (OPG) is a secreted homodimer protein that belongs to tumor necrosis factor receptor superfamily. OPG is highly expressed in fetal kidney, liver and lung. It is up-regulated by increasing calcium-concentration in the medium and estrogens and down-regulated by glucocorticoids. OPG can have multiple effects on TNFSF10 and TNFSF11. As a decoy receptor for TNFSF11/RANKL, OPG neutralizes its function in osteoclastogenesis. OPG also inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.
  • Formulation

    Lyophilized frum a 0.2 um filtered solution of PBS, pH7.4
  • Packaging

  • ALTnames

    Tumor Necrosis Factor Receptor Superfamily Member 11B; Osteoclastogenesis InhibitoryFactor; Osteoprotegerin; TNFRSF11B; OCIF; OPG
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA